Investing Profile

Naveen Krishnan

InvestorVC
Senior Director of Venture Investment at Leaps by Bayer
leaps.bayer.com/teamBerlin, Germany
Photo of Naveen Krishnan, Leaps by Bayer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
391 CONNECTIONS
University of Cambridge Network
258 CONNECTIONS
Harvard Medical School Network
52 CONNECTIONS
Massachusetts General Hospital Network
31 CONNECTIONS
Broad Institute of MIT and Harvard Network
22 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Accent Therapeutics
Series CJan 2024$75M
$180M
Co-investors: Larry Lasky (The Column Group), Jason Rhodes (Atlas Venture)
Edifice Health
Series AApr 2021$12M
$12M
Co-investors: Paul Conley (Paladin Capital Group)
NHP Researcher in Department of Neurobiology Harvard Medical SchoolPresent
Drug Discovery Researcher (Department of Chemical Biology) Broad Institute of MIT and HarvardPresent
Drug Discovery Researcher (Center for Human Genetics Research) Massachusetts General HospitalPresent
Infectious Disease Clinical Researcher London School of Hygiene and Tropical Medicine, U. of LondonPresent
Resident Physician MedStar HealthPresent
Vice President PolarityBioPresent
Senior Director (Head) of Corporate and Business Development Aspen Neuroscience, Inc.Present
Senior Director of Venture Investment Leaps by BayerPresent
Board Member Azitra IncPresent
Board Member Edifice Health, Inc.Present
Board Member Ada HealthPresent
Board Member CellinoPresent
Board Member Woebot HealthPresent
Board Member Bloom Science, Inc.Present
Board Member Lyterian TherapeuticsPresent
SVP & Managing Director Mirae Asset Capital Life SciencePresent
Board Member Accent Therapeutics, Inc.Present
Massachusetts Institute of Technology Bachelor of Science - BS Brain and Cognitive Sciences
University of Cambridge Master of Philosophy (MPhil) Public Health